Hextend and Pentalyte China License Agreement Sample Contracts

HEXTEND AND PENTALYTE CHINA LICENSE AGREEMENT BETWEEN BIOTIME, INC. AND SUMMIT PHARMACEUTICALS INTERNATIONAL CORPORATION

Hextend and Pentalyte China License Agreement • March 30th, 2006 • Biotime Inc • Biological products, (no disgnostic substances) • California

• Contract Type
  Hextend and Pentalyte China License Agreement
• Filed
  March 30th, 2006
• Company
  Biotime Inc
• Industry
  Biological products, (no disgnostic substances)
• Jurisdiction
  California

This License Agreement, dated as of March 24, 2006, sets forth the terms under which BioTime Inc. (“BioTime”) grants Summit Pharmaceuticals International Corporation (“Summit”) the rights to develop and commercialize Hextend and PentaLyte in China and Taiwan.